{"id":1235,"date":"2022-09-01T00:00:35","date_gmt":"2022-08-31T23:00:35","guid":{"rendered":"https:\/\/blogs.exeter.ac.uk\/eri\/?p=1235"},"modified":"2022-09-01T00:00:35","modified_gmt":"2022-08-31T23:00:35","slug":"aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe","status":"publish","type":"post","link":"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/","title":{"rendered":"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE"},"content":{"rendered":"<p>The purpose of this study is to evaluate the efficacy, safety, and tolerability of brensocatib as treatment for NCFBE.<\/p>\n<p>This is an experimental clinical research study of a study drug called brensocatib. \u201cExperimental\u201d means that the study drug is currently being tested in clinical research studies, and has not been approved for use in the treatment of patients with NCFBE. In addition, \u201cexperimental\u201d means that we might not have all the information about brensocatib.<\/p>\n<p>Before new drugs can be approved and sold to treat specific diseases, they must be tested in experimental clinical research studies. The results of such studies are then provided to the regulatory authorities. Brensocatib is not approved to treat NCFBE by the United States (US) Food and Drug Administration (FDA) or United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA), but it is undergoing clinical investigations to determine if brensocatib is safe and effective.<\/p>\n<p><a href=\"https:\/\/sites.exeter.ac.uk\/eri\/wp-content\/uploads\/sites\/277\/2022\/05\/9a.-INS1007-301_ICF_UK_Main_V2.0_20210517_-localised.docx\">Click here for more information<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The purpose of this study is to evaluate the efficacy, safety, and tolerability of brensocatib as treatment for NCFBE. This is an experimental clinical research study of a study drug called brensocatib. \u201cExperimental\u201d means that the study drug is currently being tested in clinical research studies, and has not been approved for use in the [&hellip;]<\/p>\n","protected":false},"author":1049,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3,7],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE - Exeter Respiratory Research &amp; Innovation (ERI)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE - Exeter Respiratory Research &amp; Innovation (ERI)\" \/>\n<meta property=\"og:description\" content=\"The purpose of this study is to evaluate the efficacy, safety, and tolerability of brensocatib as treatment for NCFBE. This is an experimental clinical research study of a study drug called brensocatib. \u201cExperimental\u201d means that the study drug is currently being tested in clinical research studies, and has not been approved for use in the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/\" \/>\n<meta property=\"og:site_name\" content=\"Exeter Respiratory Research &amp; Innovation (ERI)\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-31T23:00:35+00:00\" \/>\n<meta name=\"author\" content=\"pfc202\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pfc202\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/\",\"url\":\"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/\",\"name\":\"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE - Exeter Respiratory Research & Innovation (ERI)\",\"isPartOf\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/#website\"},\"datePublished\":\"2022-08-31T23:00:35+00:00\",\"dateModified\":\"2022-08-31T23:00:35+00:00\",\"author\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/#\/schema\/person\/26097e72047cdb1924ea4edd5998ad55\"},\"breadcrumb\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sites.exeter.ac.uk\/eri\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/#website\",\"url\":\"https:\/\/sites.exeter.ac.uk\/eri\/\",\"name\":\"Exeter Respiratory Research & Innovation (ERI)\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sites.exeter.ac.uk\/eri\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/#\/schema\/person\/26097e72047cdb1924ea4edd5998ad55\",\"name\":\"pfc202\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/eri\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/268bf278b3371f737ca63234656e93e4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/268bf278b3371f737ca63234656e93e4?s=96&d=mm&r=g\",\"caption\":\"pfc202\"},\"url\":\"https:\/\/sites.exeter.ac.uk\/eri\/author\/pfc202\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE - Exeter Respiratory Research & Innovation (ERI)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/","og_locale":"en_US","og_type":"article","og_title":"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE - Exeter Respiratory Research & Innovation (ERI)","og_description":"The purpose of this study is to evaluate the efficacy, safety, and tolerability of brensocatib as treatment for NCFBE. This is an experimental clinical research study of a study drug called brensocatib. \u201cExperimental\u201d means that the study drug is currently being tested in clinical research studies, and has not been approved for use in the [&hellip;]","og_url":"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/","og_site_name":"Exeter Respiratory Research & Innovation (ERI)","article_published_time":"2022-08-31T23:00:35+00:00","author":"pfc202","twitter_card":"summary_large_image","twitter_misc":{"Written by":"pfc202","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/","url":"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/","name":"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE - Exeter Respiratory Research & Innovation (ERI)","isPartOf":{"@id":"https:\/\/sites.exeter.ac.uk\/eri\/#website"},"datePublished":"2022-08-31T23:00:35+00:00","dateModified":"2022-08-31T23:00:35+00:00","author":{"@id":"https:\/\/sites.exeter.ac.uk\/eri\/#\/schema\/person\/26097e72047cdb1924ea4edd5998ad55"},"breadcrumb":{"@id":"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/sites.exeter.ac.uk\/eri\/2022\/09\/01\/aspen-randomised-study-to-assess-the-effect-of-brensocatib-in-patients-with-ncfbe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.exeter.ac.uk\/eri\/"},{"@type":"ListItem","position":2,"name":"ASPEN: Randomised study to assess the effect of Brensocatib in patients with NCFBE"}]},{"@type":"WebSite","@id":"https:\/\/sites.exeter.ac.uk\/eri\/#website","url":"https:\/\/sites.exeter.ac.uk\/eri\/","name":"Exeter Respiratory Research & Innovation (ERI)","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.exeter.ac.uk\/eri\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/sites.exeter.ac.uk\/eri\/#\/schema\/person\/26097e72047cdb1924ea4edd5998ad55","name":"pfc202","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sites.exeter.ac.uk\/eri\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/268bf278b3371f737ca63234656e93e4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/268bf278b3371f737ca63234656e93e4?s=96&d=mm&r=g","caption":"pfc202"},"url":"https:\/\/sites.exeter.ac.uk\/eri\/author\/pfc202\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/posts\/1235"}],"collection":[{"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/users\/1049"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/comments?post=1235"}],"version-history":[{"count":0,"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/posts\/1235\/revisions"}],"wp:attachment":[{"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/media?parent=1235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/categories?post=1235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/eri\/wp-json\/wp\/v2\/tags?post=1235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}